A cell biology journal has retracted a 2016 paper after an investigation revealed that the corresponding author failed to include two co-authors and acknowledge the funding source.
According to the retraction notice, the Journal of Cellular Physiology retracted the paper after the University of Texas, MD Anderson Cancer Center found that last author Jin Wang had omitted two researchers from the list of authors, and had also failed to acknowledge funding from the U.S. National Institutes of Health (NIH).
Wiley Periodicals is withdrawing a biochemistry paper after mistakenly publishing it in the wrong journal.
The mistake took a few months to sort out. Wiley initially published “Protein Kinase C Is Involved in the Induction of ATP-Binding Cassette Transporter A1 Expression by Liver X Receptor/Retinoid X Receptor Agonist in Human Macrophages” online in Journal of Cellular Physiology in May of last year. The article was posted in the correct journal — Journal of Cellular Biochemistry — in July.
At the very end of 2015, the publisher officially withdrew the version it posted in the Journal of Cellular Physiology.
Authors of a study on a potential biomarker for ovarian cancer have been hit with two retractions after the results were published twice.
We don’t usually see both copies of a duplicated paper retracted, but this is a somewhat unusual case. In November 2011, a group of authors submitted the paper to Gynecologic Oncology. But two months’ prior, the first author had decided to also submit the paper to the Journal of Cellular Physiology, without listing three of the other researchers, including the primary author on the paper. It was published by the Journal of Cellular Physiology first, then by Gynecologic Oncology, both in July, 2012.
Jie Chen, first author on both articles, “takes full responsibility for the dual submission” and “other co-authors should be exempted from all responsibilities,” as the retraction notice from Gynecologic Oncologyexplains.
The blog lists six papers by the pair with supposedly questionable figures. According to Jigen, this latest retraction, in the Journal of Cellular Physiology, contains a figure (2A) that appears to reuse data from another paper, and another figure (3) where the data appear to be manipulated.
The article, “Early Years of Biological Agents Therapy in Crohn’s Disease and Risk of the Human Polyomavirus JC Reactivation,” was led by Valeria Pietropaolo, of Sapienza University in Rome and the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia.
The paper has been cited 10 times, according to Thomson Scientific’s Web of Knowledge. The abstract, which is still available, reads:
We’ve been covering the case of Alirio Melendez, three of whose papers have been retracted amidst questions about almost 70 studies. The latest development is a correction in the Journal of Cellular Physiology, which has already retracted one of his papers, of a study on which he was a co-author.
Alirio Melendez, the former National University of Singapore researcher who has already retracted two papers in the midst of an investigation into about 70 of his publications, has had a third retracted a third.
Last month, we reported that the last three of six promised retractions by Zhiguo Wang, who was a researcher at the Montreal Heart Institute until the results of an Institute investigation forced him to resign in early September — would be in the Journal of Cellular Physiology. They’ve now appeared.